Pharmaceutical Grade Yellow Dextrin

Updated: 2026-09-11

Overview

Pharmaceutical Grade Yellow Dextrin is a hydrolyzed starch derivative produced through controlled thermal and acid treatment of corn or potato starch. Unlike industrial dextrins, this pharmacopeia-compliant variant undergoes additional purification to remove residual acids and byproducts, ensuring suitability for human pharmaceutical applications. As a multifunctional excipient, it serves critical roles in solid dosage formulations, particularly where controlled disintegration and binding properties are required. Its yellow coloration distinguishes it from white dextrin variants, though both share similar functional characteristics in drug formulation systems.

Physical and Chemical Properties

This dextrin exhibits a consistent particle size distribution (typically 80-120 mesh) with bulk densities ranging from 0.5-0.7 g/cm³. Its low hygroscopic nature (<10% moisture absorption at 60% RH) makes it particularly valuable for moisture-sensitive formulations. The material demonstrates excellent thermal stability up to 150°C, crucial for tablet compression processes. Chemically, it consists of α-(1,4) and α-(1,6) linked glucose units with varying chain lengths (DE value 10-20). The partial hydrolysis creates optimal viscosity characteristics—forming stable gels at 10-15% concentrations in water while maintaining rapid dissolution profiles required for pharmaceutical disintegration standards.

Main Applications

In tablet manufacturing, this dextrin functions primarily as a dry binder in direct compression (20-30% w/w) or as a binder in wet granulation (5-15% solution). Its adhesive properties enable robust tablet formation without compromising dissolution rates. The material is USP-NF listed for use in oral dosage forms including chewable tablets where its mild sweetness enhances palatability. Additional applications include capsule filling (as a flow aid), lozenge formulations, and as a stabilizer in herbal extracts. Recent innovations utilize its film-forming properties for controlled-release matrix systems. In veterinary pharmaceuticals, it serves similar functions while meeting lower cost thresholds compared to synthetic alternatives.

Safety and Storage

Classified as GRAS (Generally Recognized As Safe) by FDA, this dextrin requires standard industrial hygiene practices—use dust control measures during handling to prevent respiratory irritation. Though non-toxic, excessive airborne concentrations (>10 mg/m³) may create explosive dust atmospheres, necessitating appropriate electrical classifications in processing areas. Proper storage involves double-layer moisture-proof bags placed on pallets in warehouses with <60% humidity. Shelf life typically exceeds 36 months when stored correctly. Quality degradation manifests through darkening color or clumping—such material should be retested for viscosity and microbial limits before use in GMP production.

B2B Procurement Guide

Pharmaceutical buyers should prioritize suppliers with ISO 13485 or cGMP certification for excipient manufacturing. Key procurement criteria include: batch-to-batch consistency in viscosity (typically 100-300 cP for 10% solutions), residual solvent levels (<5000 ppm), and microbiological counts (<1000 CFU/g). For large-scale purchases (5+ metric tons), negotiate based on testing protocols—some manufacturers offer discounted pricing for waived in-house testing when accepting their CoA. Consider regional sourcing in North America or Europe for shorter lead times, though Asian producers often offer 15-20% cost advantages for annual contracts. Always validate supply chain documentation for excipient GDP compliance.